INS and myocardial infarction: According to preliminary studies, MI patients benefited from HPA mainly by improving risk profiles, such as lowering triglyceride and increasing high-density lipoprotein cholesterol levels (25), lowering blood pressure (26), improving glucose metabolism and insulin sensitivity (27), and reducing BMI and inflammatory cytokines (28).